These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1286 related items for PubMed ID: 10999768

  • 21. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.
    Graeven U, Rodeck U, Karpinski S, Jost M, Philippou S, Schmiegel W.
    Cancer Res; 2001 Oct 01; 61(19):7282-90. PubMed ID: 11585767
    [Abstract] [Full Text] [Related]

  • 22. Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity.
    Tortora G, Caputo R, Damiano V, Caputo R, Troiani T, Veneziani BM, De Placido S, Bianco AR, Zangemeister-Wittke U, Ciardiello F.
    Clin Cancer Res; 2003 Feb 01; 9(2):866-71. PubMed ID: 12576461
    [Abstract] [Full Text] [Related]

  • 23. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM.
    Cancer; 2000 Aug 01; 89(3):488-99. PubMed ID: 10931447
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM.
    Medicina (B Aires); 2000 Aug 01; 60 Suppl 2():41-7. PubMed ID: 11188930
    [Abstract] [Full Text] [Related]

  • 25. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 01; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.
    Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H.
    Cancer Res; 1995 Nov 15; 55(22):5296-301. PubMed ID: 7585591
    [Abstract] [Full Text] [Related]

  • 27. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L, Yu D, Hu M, Xiong S, Lang A, Ellis LM, Pollock RE.
    Cancer Res; 2000 Jul 01; 60(13):3655-61. PubMed ID: 10910082
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.
    Kondo Y, Arii S, Mori A, Furutani M, Chiba T, Imamura M.
    Clin Cancer Res; 2000 Feb 01; 6(2):622-30. PubMed ID: 10690548
    [Abstract] [Full Text] [Related]

  • 30. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines.
    Ke LD, Shi YX, Im SA, Chen X, Yung WK.
    Clin Cancer Res; 2000 Jun 01; 6(6):2562-72. PubMed ID: 10873113
    [Abstract] [Full Text] [Related]

  • 31. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production.
    Zeng G, Gao L, Birklé S, Yu RK.
    Cancer Res; 2000 Dec 01; 60(23):6670-6. PubMed ID: 11118051
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma.
    Dagnaes-Hansen F, Rasmussen LM, Tilton R, Denner L, Flyvbjerg A.
    Anticancer Res; 2003 Dec 01; 23(2B):1625-30. PubMed ID: 12820432
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
    Murakami K, Sakukawa R, Sano M, Hashimoto A, Shibata J, Yamada Y, Saiki I.
    Clin Cancer Res; 1999 Sep 01; 5(9):2304-10. PubMed ID: 10499597
    [Abstract] [Full Text] [Related]

  • 38. Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin.
    Borgström P, Gold DP, Hillan KJ, Ferrara N.
    Anticancer Res; 1999 Sep 01; 19(5B):4203-14. PubMed ID: 10628376
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.